At FyoniBio, we bring together a combination of services and expertise that's rarely found in one place. Our offering spans from CMC development to clinical analytics, a range that's typically split across multiple providers.
We bring everything together: cell line and bioprocess development, analytical characterization – including in-depth mass spectrometry analysis – and clinical bioanalysis — all under one roof. This integration helps our clients reduce handovers, avoid miscommunication, and keep development moving smoothly.
Our deep scientific knowledge in glycobiology is rare in the industry. We’ve built in-house expertise that allows us to analyze virtually every aspect of glycosylation and tune many glycosylation characteristics on biopharmaceuticals—a capability few others can match.
Our cell line development platform is one of the most comprehensive worldwide. From complex genetic engineering to non-standard analytical methods, we’re equipped to take on demanding projects. And we’re always thinking ahead — using the latest technologies in ways that are not just effective, but also cost-efficient and scalable.
“For us, good collaboration starts with honesty, openness, and a shared goal. With many years in the biotech industry, we focus on delivering reliable, scientifically solid solutions—while always being available for a conversation, a fresh perspective, or simply helping our clients and team move forward with confidence.”
“What we enjoy most is getting new projects off the ground and finding analytical solutions that truly support our clients — especially when it comes to clinical development. At FyoniBio, we work closely as a team, and this strong internal connection makes it easy to collaborate openly and reliably with our partners. It’s a shared effort, and it’s what helps us deliver results that matter.”
FyoniBio began as the service unit within Glycotope, a clinical-stage immuno-oncology company built on world-leading glycobiology expertise. Over the years, our team supported Glycotope’s proprietary pipeline with deep scientific know-how across cell line development, bioprocessing, analytics, and clinical bioanalysis.
In early 2019, structural changes at Glycotope brought the risk of layoffs — and with them, the potential loss of a highly skilled and experienced team. FyoniBio’s managing directors, Lars Stöckl, PhD, and Hans Baumeister, PhD, saw an opportunity instead:
“There’s so much knowledge and experience in this service unit. It would be a shame to lose it.”
And this is how FyoniBio started its own path in early 2022 – preserving its knowledge and expertise, and focusing solely on supporting the biopharmaceutical industry.
FyoniBio Team
We’re scientists, thinkers, and doers — and we would enjoy working together with you. Your project won’t land in a black box. We stay in touch, ask the right questions, and keep things moving — with care, clarity, and curiosity.
What truly drives us is the scientific curiosity and care we bring to every project. We work with our heads and our hearts. We don’t pretend to be perfect — we know that science involves trial and error. But we take full responsibility, drawing on our experience to help clients navigate complex questions and uncover the best possible path forward.
From the very beginning, we set out to build more than just a service company. In one of our first team meetings as an independent business, we put it plainly:
“We want to create a place where we like to work.”
That idea still guides us today. Of course, technology, quality, and sustainable business matter — they’re what keep us going. But at the heart of FyoniBio is something equally important: a supportive and collaborative atmosphere, where people know what their colleagues are working on and are ready to lend a hand.
We value transparency, and we don’t shy away from challenges or difficult conversations. Instead, we try to proactively address tensions before they grow, not to stay positive 100% of the time, but to build real trust and a sense of team.
Expanding Your Path to Market Through Seamless Collaboration
We work closely with a trusted network of GMP-certified partners to ensure smooth transitions from development to clinical and commercial manufacturing.
Let's discuss how our integrated approach can support your biopharma journey.
© FyoniBio GmbH 2025
Illustration designer: Tilo Schneider
